ArticleClinical trials (London, England)2025
BARD: A seamless two-stage dose optimization design integrating backfill and adaptive randomization.
Yixuan Zhao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it